Overview

Clinical Application of IRE Combined With Chemotherapy in the Treatment of Pancreatic Cancer

Status:
Recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The aim of this study was to observe the survival status, recurrence and death time of patients with pancreatic cancer treated by chemotherapy combined with IRE. The survival and overall survival of the patients were evaluated respectively.
Phase:
Phase 1
Details
Lead Sponsor:
Fuda Cancer Hospital, Guangzhou
Treatments:
Gemcitabine